Cargando…

Progression of puberty after initiation of androgen therapy in patients with idiopathic hypogonadotropic hypogonadism

BACKGROUND: Onset of puberty in boys usually occurs by 14 years of age. Some boys may exhibit delayed sexual maturation till about 17-18 years of age. However, pubertal onset beyond 18 years of age is exceedingly rare. MATERIALS AND METHODS: Patients diagnosed as idiopathic hypogonadotropic hypogona...

Descripción completa

Detalles Bibliográficos
Autores principales: Kulshreshtha, Bindu, Khadgawat, Rajesh, Gupta, Nandita, Ammini, Ariachery
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3784868/
https://www.ncbi.nlm.nih.gov/pubmed/24083166
http://dx.doi.org/10.4103/2230-8210.117245
_version_ 1782477602759376896
author Kulshreshtha, Bindu
Khadgawat, Rajesh
Gupta, Nandita
Ammini, Ariachery
author_facet Kulshreshtha, Bindu
Khadgawat, Rajesh
Gupta, Nandita
Ammini, Ariachery
author_sort Kulshreshtha, Bindu
collection PubMed
description BACKGROUND: Onset of puberty in boys usually occurs by 14 years of age. Some boys may exhibit delayed sexual maturation till about 17-18 years of age. However, pubertal onset beyond 18 years of age is exceedingly rare. MATERIALS AND METHODS: Patients diagnosed as idiopathic hypogonadotropic hypogonadism (IHH) who had onset of puberty (increase in testicular volume >10 ml) while on androgen therapy were studied. These patients were evaluated prospectively. RESULTS: There were nine subjects that were included in the study. The pre-therapy testicular volumes ranged from 3 to 6 ml. Luteinizing hormone (LH) levels increased from 1.2 ± 0.96 to 2.8 ± 1.0 IU/L, follicular stimulating hormone (FSH) levels increased from 1.5 ± 0.79 to 3.5 ± 1.9 IU/L, and testosterone increased from 0.36 ± 0.16 to 3.4 ± 2.1 ng/ml. Three out of nine patients had testosterone levels below 3 ng/ml. CONCLUSION: Our present study indicates that pubertal development can occur in patients presenting with hypogonadotropic hypogonadism after 18 years of age. However, acquired pubertal status may be subnormal
format Online
Article
Text
id pubmed-3784868
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-37848682013-09-30 Progression of puberty after initiation of androgen therapy in patients with idiopathic hypogonadotropic hypogonadism Kulshreshtha, Bindu Khadgawat, Rajesh Gupta, Nandita Ammini, Ariachery Indian J Endocrinol Metab Original Article BACKGROUND: Onset of puberty in boys usually occurs by 14 years of age. Some boys may exhibit delayed sexual maturation till about 17-18 years of age. However, pubertal onset beyond 18 years of age is exceedingly rare. MATERIALS AND METHODS: Patients diagnosed as idiopathic hypogonadotropic hypogonadism (IHH) who had onset of puberty (increase in testicular volume >10 ml) while on androgen therapy were studied. These patients were evaluated prospectively. RESULTS: There were nine subjects that were included in the study. The pre-therapy testicular volumes ranged from 3 to 6 ml. Luteinizing hormone (LH) levels increased from 1.2 ± 0.96 to 2.8 ± 1.0 IU/L, follicular stimulating hormone (FSH) levels increased from 1.5 ± 0.79 to 3.5 ± 1.9 IU/L, and testosterone increased from 0.36 ± 0.16 to 3.4 ± 2.1 ng/ml. Three out of nine patients had testosterone levels below 3 ng/ml. CONCLUSION: Our present study indicates that pubertal development can occur in patients presenting with hypogonadotropic hypogonadism after 18 years of age. However, acquired pubertal status may be subnormal Medknow Publications & Media Pvt Ltd 2013 /pmc/articles/PMC3784868/ /pubmed/24083166 http://dx.doi.org/10.4103/2230-8210.117245 Text en Copyright: © Indian Journal of Endocrinology and Metabolism http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Kulshreshtha, Bindu
Khadgawat, Rajesh
Gupta, Nandita
Ammini, Ariachery
Progression of puberty after initiation of androgen therapy in patients with idiopathic hypogonadotropic hypogonadism
title Progression of puberty after initiation of androgen therapy in patients with idiopathic hypogonadotropic hypogonadism
title_full Progression of puberty after initiation of androgen therapy in patients with idiopathic hypogonadotropic hypogonadism
title_fullStr Progression of puberty after initiation of androgen therapy in patients with idiopathic hypogonadotropic hypogonadism
title_full_unstemmed Progression of puberty after initiation of androgen therapy in patients with idiopathic hypogonadotropic hypogonadism
title_short Progression of puberty after initiation of androgen therapy in patients with idiopathic hypogonadotropic hypogonadism
title_sort progression of puberty after initiation of androgen therapy in patients with idiopathic hypogonadotropic hypogonadism
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3784868/
https://www.ncbi.nlm.nih.gov/pubmed/24083166
http://dx.doi.org/10.4103/2230-8210.117245
work_keys_str_mv AT kulshreshthabindu progressionofpubertyafterinitiationofandrogentherapyinpatientswithidiopathichypogonadotropichypogonadism
AT khadgawatrajesh progressionofpubertyafterinitiationofandrogentherapyinpatientswithidiopathichypogonadotropichypogonadism
AT guptanandita progressionofpubertyafterinitiationofandrogentherapyinpatientswithidiopathichypogonadotropichypogonadism
AT amminiariachery progressionofpubertyafterinitiationofandrogentherapyinpatientswithidiopathichypogonadotropichypogonadism